Raymond James Financial’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Raymond James Financial's ASND Position: Q3 2026 in Review
Raymond James Financial reduced its Ascendis Pharma (ASND) stake by 11% in Q3 2026, selling an estimated $192K and leaving 6,144 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3785.
Raymond James Financial first reported a position in ASND in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.98M in Q1 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Raymond James Financial held 6,144 shares of Ascendis Pharma worth $1.4M as of Q3 2026.
- Raymond James Financial sold 757 Ascendis Pharma shares in Q3 2026, an estimated $192K.
- Ascendis Pharma made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #3785 holding.
- Raymond James Financial first reported a position in Ascendis Pharma in Q1 2025 and has held it in 7 quarters since.
- Raymond James Financial's Ascendis Pharma position peaked at $1.98M in Q1 2026.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.